Epic Research Update : Ranbaxy Laboratories

Ranbaxy Laboratories and US drugmaker Teva have jointly agreed to settle an investigation launched by the New York Attorney General alleging the two rival generic drug makers made an unlawful agreement to restrict competition. As part of the settlement of the claim, the companies will terminate an agreement not to challenge each other’s rights to sell certain generic drugs exclusively in the US and also agreed to refrain from entering into similar agreements in the future, besides paying a penalty of $300,000.


For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips